Ethan P. Lutske
Partner
-
Experience in Cross-Border Transactions
Ethan has worked on transactions across North America, Asia, and Europe.
-
Broad Transactions Experience
Ethan has represented numerous clients in both public and private mergers, tender offers, asset acquisitions, stock purchases, joint ventures, and other strategic corporate transactions.
Ethan Lutske is a partner in Wilson Sonsini Goodrich & Rosati's mergers and acquisitions practice. He has worked on transactions across North America, Asia, and Europe. He has represented numerous clients in both public and private mergers, tender offers, asset acquisitions, stock purchases, joint ventures, SPAC transactions, reverse mergers, and other strategic corporate transactions.
Experience
Ethan Lutske is a partner in Wilson Sonsini Goodrich & Rosati's mergers and acquisitions practice. He has worked on transactions across North America, Asia, and Europe. He has represented numerous clients in both public and private mergers, tender offers, asset acquisitions, stock purchases, joint ventures, SPAC transactions, reverse mergers, and other strategic corporate transactions.
Education
- J.D., New York University, 2010
- B.A., Political Science and Economics, University of California, Berkeley, 2007
Honors
- Recognized among Daily Journal’s 2024 “Top 40 Under 40”
Admissions
- State Bar of California
Credentials
Education
- J.D., New York University, 2010
- B.A., Political Science and Economics, University of California, Berkeley, 2007
Honors
- Recognized among Daily Journal’s 2024 “Top 40 Under 40”
Admissions
- State Bar of California
Select Transactions
Strategic Transactions
- Jony Ive and LoveFrom in Open AI’s acquisition of IO Products and partnership with LoveFrom
- Windsurf in its sale to Cognition
- Salesforce, Google, AppDirect, Aurora Innovation, Arista, Encora, Rambus, and others in numerous acquisition transactions
- Whitehawk Therapeutics in its sale of its Fyarro business to Kaken
- Fluent Biosciences in its sale to Illumina
- IDbyDNA in its sale to Illumina
- Namocell in its sale to Bio-Techne
- CloudGenix in its sale to Palo Alto Networks
- Transplant Genomics in its sale to EuroFins
- Lucky's Market in its strategic combination with Krogers
- NanoString Technologies in its sale of a business line to Veracyte
- Semnur Pharmaceuticals in its sale to Sorrento Pharmaceuticals
Public Company Acquisitions
- VMWare in its acquisition of Pivotal.io
- Pfenex in its sale to Ligand
- Electro Scientific Industries in its sale to MKS
- Invuity in its sale to Stryker Corporation
- Miramar Labs in its sale to Sientra
- Cyan Inc. its sale to Ciena
- Integrated Silicon Solution Inc. in its sale to a consortium of Chinese investors
SPAC and Reverse Merger Transactions
- Numerous operating companies in reverse merger and de-SPAC transactions, including:
- Aurora Innovation
- Lenz Therapeutics
- OnKure Therapeutics
- Aadi Biosciences
- Forte Biosciences
- Sonder
- ESS Tech
- Amprius
- Solid Power
- Inspirato
- Various representations of SPACs and similar public companies in their transactions across from operation companies in reverse merger and de-SPAC transactions, including SK Growth Opportunity and Arca Biopharma.
Other Cross-Border Transactions
- FanDuel in its business combination with the U.S. operations of Paddy Power Betfair
- Infinera in its acquisition of Coriant International
- GaN Systems in its sale to Infineon
- Marvell Technology in its divestiture of its automotive ethernet business to Infineon
- Bear Robotics in its business combination with LG’s robotics division
- Onfido in its sale to Entrust
- Run.ai Labs in its sale to NVIDIA
- Silk Security in its sale to Armis
- TSI Japan in its acquisition of HUF Worldwide
Matters
Select Transactions
Strategic Transactions
- Jony Ive and LoveFrom in Open AI’s acquisition of IO Products and partnership with LoveFrom
- Windsurf in its sale to Cognition
- Salesforce, Google, AppDirect, Aurora Innovation, Arista, Encora, Rambus, and others in numerous acquisition transactions
- Whitehawk Therapeutics in its sale of its Fyarro business to Kaken
- Fluent Biosciences in its sale to Illumina
- IDbyDNA in its sale to Illumina
- Namocell in its sale to Bio-Techne
- CloudGenix in its sale to Palo Alto Networks
- Transplant Genomics in its sale to EuroFins
- Lucky's Market in its strategic combination with Krogers
- NanoString Technologies in its sale of a business line to Veracyte
- Semnur Pharmaceuticals in its sale to Sorrento Pharmaceuticals
Public Company Acquisitions
- VMWare in its acquisition of Pivotal.io
- Pfenex in its sale to Ligand
- Electro Scientific Industries in its sale to MKS
- Invuity in its sale to Stryker Corporation
- Miramar Labs in its sale to Sientra
- Cyan Inc. its sale to Ciena
- Integrated Silicon Solution Inc. in its sale to a consortium of Chinese investors
SPAC and Reverse Merger Transactions
- Numerous operating companies in reverse merger and de-SPAC transactions, including:
- Aurora Innovation
- Lenz Therapeutics
- OnKure Therapeutics
- Aadi Biosciences
- Forte Biosciences
- Sonder
- ESS Tech
- Amprius
- Solid Power
- Inspirato
- Various representations of SPACs and similar public companies in their transactions across from operation companies in reverse merger and de-SPAC transactions, including SK Growth Opportunity and Arca Biopharma.
Other Cross-Border Transactions
- FanDuel in its business combination with the U.S. operations of Paddy Power Betfair
- Infinera in its acquisition of Coriant International
- GaN Systems in its sale to Infineon
- Marvell Technology in its divestiture of its automotive ethernet business to Infineon
- Bear Robotics in its business combination with LG’s robotics division
- Onfido in its sale to Entrust
- Run.ai Labs in its sale to NVIDIA
- Silk Security in its sale to Armis
- TSI Japan in its acquisition of HUF Worldwide
Recent Insights
Client Highlights
Wilson Sonsini Advises Contentful on Acquisition by Salesforce
On June 1, 2026, Salesforce, the world's No. 1 AI CRM, announced that it has signed a definitive agreement to acquire Contentful, a leading composable content platform trusted by over 4,800 of the world’s leading brands to deliver personalized digital experiences at scale. Wilson Sonsini Goodrich & Rosati advised Contentful on the transaction.
Learn More
Client Highlights
Firm Advises Katana on Its Acquisition of IDEX
On March 23, 2026, Katana, a DeFi blockchain built around a tightly integrated trading stack, announced it has completed the acquisition of IDEX, a decentralized exchange and on-chain trading infrastructure team, and launched Katana Perps, a native perpetual futures platform. Katana was incubated by Polygon and GSR Markets. Wilson Sonsini Goodrich & Rosati advised Katana on the transaction.
Learn More
Recent Events
Affiliated Programs
The L Suite Webinar: Buying the Team, Not the Company - Legal and Structuring Considerations in Acquihires
Wilson Sonsini will co-host The L Suite’s “Buying the Team, Not the Company: Legal and Structuring Considerations in Acquihires” webinar on March 31, 2026.
Learn More
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.